Moderna, Inc. (MRNA)

68.36
0.53 0.78
NASDAQ
Prev Close 67.83
Open 68.06
Day Low/High 67.86 / 70.36
52 Wk Low/High 12.47 / 95.21
Volume 10.60M
Exchange NASDAQ
Shares Outstanding 394.59B
Market Cap 27.43B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Mitch's Hurtful Words, Tuesday's Tumble, Do-Nothing Congress: Market Recon

Mitch's Hurtful Words, Tuesday's Tumble, Do-Nothing Congress: Market Recon

Plus, quick looks at Joe Biden's VP choice, the latest on the Covid-19 vaccine front and Tesla's stock split.

The Rally Broadens, Dow Theory, Virus Cocktail, 4 Questions: Market Recon

The Rally Broadens, Dow Theory, Virus Cocktail, 4 Questions: Market Recon

Markets may believe that we are closer to the effective use of vaccines and therapeutics than we know in this battle against Covid-19.

Jim Cramer: Betting Against Science Is a Mug's Game

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Jim Cramer: Clorox, Covid and Indecision on Packaged Goods Stocks

Jim Cramer: Clorox, Covid and Indecision on Packaged Goods Stocks

The whole group has run and the guidance from Clorox does show, more than anything, that nobody knows.

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.

Jim Cramer: Here Are My Top 10 Pandemic Paradox Stocks

Jim Cramer: Here Are My Top 10 Pandemic Paradox Stocks

In a 'normal' recession, these would be real losers -- but right now? They look like numero 'UNO'.

Danger Beneath the Waves, Chip Stocks Ahoy, Fiscal Battle, Sizing Up Starbucks

Danger Beneath the Waves, Chip Stocks Ahoy, Fiscal Battle, Sizing Up Starbucks

Negotiations on the next round of stimulus, more so than tension between Washington and Beijing, and more so than earnings season, will control short-term financial market performance.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Caution Signs, Laboring Labor Market, Gold Watch and Ugly Intel: Market Recon

Caution Signs, Laboring Labor Market, Gold Watch and Ugly Intel: Market Recon

Plus, why shares of vaccine maker Moderna are taking a hit.

A Complete Review of the Past Week's Macroeconomic Developments

Here is a summary of this week's major macroeconomic events:  The Positives  1) Moderna , while still having to progress thru phase 3 trials, reported positive antibody results from phase 1 data and brings us a step closer to that hoped for vaccine....

Jim Cramer: An Analyst's Dream

Jim Cramer: An Analyst's Dream

All we have to do is take our cue from companies that boosted their forecasts but their stocks did nothing.

Small Caps Make Some Big Noise

Small Caps Make Some Big Noise

FAANG stocks lag while the Russell rises, bringing divergences and questions.

Treasury Yields Post-Covid, Reading Fed Tea Leaves and Junk Bond Intrigue

Treasury Yields Post-Covid, Reading Fed Tea Leaves and Junk Bond Intrigue

A Fed governor speaks of accommodation, and AMC Entertainment's bond maneuvers serve as a warning to those who swim in the high-yield pool.

The Only Certainty Is the Lack of Certainty

* Much like the Wild West, the market's action has turned unpredictable and volatile -- with little of a thematic character, save trading within a defined range and with some outstanding (and speculative) characters. The encouraging announcement of ...

An Ugly Intraday Reversal Turns Into a Bear Trap

An Ugly Intraday Reversal Turns Into a Bear Trap

Stock picking continues to be the most productive approach as market timers are battered and bruised once again.

Jim Cramer: How Do You Refute These Market Gains?

Jim Cramer: How Do You Refute These Market Gains?

This is pretty much exactly what you get when you have so much positive research.

Moderna Rated New Buy at Jefferies

Novavax and Its $1.6 Billion Award Just Got My Attention

Novavax and Its $1.6 Billion Award Just Got My Attention

The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.

Q2 Earnings Expectations, Phase 3 Vaccine Clinical Trials, Unemployment Numbers

Q2 Earnings Expectations, Phase 3 Vaccine Clinical Trials, Unemployment Numbers

What if the market is simply pricing in a quarter that had already been priced out?

I Wouldn't Buy Pfizer Shares on This Pop

I Wouldn't Buy Pfizer Shares on This Pop

I would wait until the next down day, and there will be one.

Covid-19 Complications, Grocery Store-y, More on Moderna: Market Recon

Covid-19 Complications, Grocery Store-y, More on Moderna: Market Recon

Plus, a closer look at Thursday's late-day rally and at actions impacting the nation's big banks.

Tesla Shares May Power Down a Bit Near Term

Tesla Shares May Power Down a Bit Near Term

The charts of the electric vehicle maker are showing some weakening in the stock, though a major shake-out isn't likely.

Jim Cramer: Are You a Star Player? Let's Put It to the Test

Jim Cramer: Are You a Star Player? Let's Put It to the Test

Do you know what a company does, does it do it well, and is there anything going on that could change the trajectory?

Jim Cramer: Is the Market More Dangerous Because of 3 New Constituencies?

Jim Cramer: Is the Market More Dangerous Because of 3 New Constituencies?

I can't educate the foreign investors. The professional mutual fund managers think I'm dead wrong. But I can help teach the new retail traders.

Here's How I'm Actively Managing Assets

Here's How I'm Actively Managing Assets

This market is offering trading opportunities the likes of which haven't been seen since early 2009.

Risky Business, Painful Recovery, Trading Thoughts

Risky Business, Painful Recovery, Trading Thoughts

The massive tock market drop was to be expected, and seasoned traders were prepared for it. But there was also some good news on the coronavirus vaccine/treatment front.

Warp Speed for 5 Vaccine Candidates, Watching KLA Corp, Trading Thoughts

Warp Speed for 5 Vaccine Candidates, Watching KLA Corp, Trading Thoughts

The administration will provide increased financial support to 5 pharmas working on Covid vaccines, and we must keep an eye on price action in this uncertain market.